Earnings call transcript: Lockheed Martin misses Q1 2026 EPS and revenue forecasts

Lockheed Martin’s Q1 2026 results missed expectations, with EPS of $6.44 versus $6.74 consensus and revenue of $18.0B versus $18.26B, while shares fell 4.76% in pre-market trading. Free cash flow was negative $291M due to ERP-related working-capital timing, though management reaffirmed full-year sales growth, $8.4B-$8.7B profit guidance, and $6.5B-$6.8B free cash flow guidance. Strength in Missiles and Fire Control offset weakness in Aeronautics and RMS, and management highlighted major defense demand, Artemis II, and AI initiatives as longer-term positives.

Analysis

The key takeaway is not the quarter itself but the market’s growing split between near-term execution noise and multi-year demand visibility. LMT is still converting geopolitical stress into backlog, but the equity is now priced like a quality industrial rather than a quasi-staples defense compounder, so any operational stumble gets punished disproportionately while the strategic story remains intact. That creates a window for relative-value rather than outright directional exposure: the earnings miss is a timing problem, but the production ramp and contract structure can re-rate the stock if management executes on cash conversion over the next 2-3 quarters.

The second-order winner is the missile-defense supply chain. If LMT’s ramp narrative is real, the bottlenecks migrate upstream to seekers, solid rocket motors, specialty electronics, and test capacity, which favors diversified defense suppliers with cleaner execution and less single-program risk. GD and LHX should see incremental benefit as preferred partners in the capacity expansion, while lower-tier subcontractors with constrained manufacturing footprints may capture pricing power before LMT’s own margins fully recover.

The main risk is that the market is underestimating how long ERP/cash-flow friction can linger even when management says it is temporary. If working capital remains elevated into Q2, the stock could stay range-bound for weeks, but the bigger catalyst is a clean cash inflection plus evidence that the missile ramp is translating into margin, not just revenue. A faster-than-expected restoration of free cash flow would likely force shorts to cover because the bear case depends on the company looking operationally impaired, not merely noisy.

Consensus may be too focused on the quarter’s miss and too little on the pricing of future capacity optionality. The overreaction is likely in the stock, not the business, but the timing still matters: near-term upside is capped until the cash narrative improves. The best setup is to own LMT versus weaker execution peers or against industrial cyclicals if defense order flow remains insulated from macro slowing.

Key Decisions for Investors

• Buy LMT on weakness over the next 1-3 weeks, targeting a 3-6 month rebound if Q2 cash flow normalizes; risk/reward improves materially below recent pre-market levels because the market is discounting a prolonged execution issue that management says is transitory.
• Pair trade: long LMT / short BA for 3-6 months. LMT has geopolitical backlog support and capital returns, while BA remains a cleaner expression of execution risk; this isolates defense demand from industrial delivery noise.
• Overweight GD and LHX versus LMT into the next 1-2 quarters. If missile-defense capacity expansion is the real structural winner, the supplier ecosystem should capture earlier margin expansion than the prime contractor.
• Consider a tactical call spread in LMT for the next earnings cycle only if Q2 cash flow inflects: use a limited-risk structure to express upside from a sentiment reset without paying for full delta in a still-cautious tape.
• For more defensive exposure, buy a basket of missile-defense enablers on any further weakness in the defense group; the second-order beneficiaries are the companies supplying propulsion, seekers, and electronics rather than the headline prime itself.